Soligenix Inc. (SNGX)

NASDAQ HEALTHCARE
$0.34 -19.70% RSI 19 Oversold Add Alert

Moving Averages

SMA 200
$1.65
Price below

Company Profile

Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$11.54M
P/E Ratio
None
EPS
$-2.14
Beta
1.938
Dividend Yield
0.00%
52-Week High
$6.23
52-Week Low
$1

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0
SRPT
Sarepta Therapeutics Inc
RSI 51.0

Data last updated: April 11, 2026 at 7:23 AM EDT

Track SNGX for free

Get e-mail RSI alerts when Soligenix Inc. enters oversold or overbought territory. Free forever.

Add Alert